Source:http://linkedlifedata.com/resource/pubmed/id/19586083
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
2009-7-9
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
T
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1170-7690
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
27
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
435-8
|
| pubmed:meshHeading |
pubmed-meshheading:19586083-Drug Costs,
pubmed-meshheading:19586083-Drug Prescriptions,
pubmed-meshheading:19586083-Drugs, Generic,
pubmed-meshheading:19586083-Germany,
pubmed-meshheading:19586083-Humans,
pubmed-meshheading:19586083-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:19586083-Proton Pump Inhibitors
|
| pubmed:year |
2009
|
| pubmed:articleTitle |
Update of recent reforms in Germany to enhance the quality and efficiency of prescribing of proton pump inhibitors and lipid-lowering drugs.
|
| pubmed:publicationType |
Letter
|